Valbiotis S.A.
ALVAL.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | €0 | €5 | €1 | €0 |
| % Growth | -96.3% | 502.9% | 163.4% | – |
| Cost of Goods Sold | €3 | €2 | €0 | €0 |
| Gross Profit | -€2 | €3 | €1 | €0 |
| % Margin | -1,396% | 56.8% | 97.7% | 94.6% |
| R&D Expenses | €4 | €7 | €9 | €7 |
| G&A Expenses | €4 | €2 | €1 | €0 |
| SG&A Expenses | €8 | €4 | €2 | €1 |
| Sales & Mktg Exp. | €4 | €2 | €1 | €1 |
| Other Operating Expenses | -€4 | -€1 | €2 | €1 |
| Operating Expenses | €8 | €10 | €13 | €9 |
| Operating Income | -€10 | -€7 | -€14 | -€11 |
| % Margin | -5,956% | -151.3% | -1,790.4% | -3,648% |
| Other Income/Exp. Net | €0 | -€2 | -€0 | €0 |
| Pre-Tax Income | -€10 | -€9 | -€14 | -€10 |
| Tax Expense | €0 | -€2 | -€2 | -€2 |
| Net Income | -€10 | -€7 | -€12 | -€9 |
| % Margin | -5,728.6% | -155.7% | -1,568.4% | -2,913.1% |
| EPS | -0.63 | -0.59 | -1.22 | -0.95 |
| % Growth | -6.8% | 51.6% | -28.4% | – |
| EPS Diluted | -0.63 | -0.59 | -1.22 | -0.95 |
| Weighted Avg Shares Out | 16 | 12 | 10 | 9 |
| Weighted Avg Shares Out Dil | 16 | 12 | 10 | 9 |
| Supplemental Information | – | – | – | – |
| Interest Income | €1 | €0 | €0 | €0 |
| Interest Expense | €0 | €0 | €0 | €0 |
| Depreciation & Amortization | €1 | €1 | €1 | €1 |
| EBITDA | -€9 | -€6 | -€11 | -€9 |
| % Margin | -5,241.1% | -135.5% | -1,418.3% | -3,067.8% |